Clinical trials on the pharmacological treatment of long COVID: A systematic review

YJ Chee, BE Fan, BE Young, R Dalan… - Journal of medical …, 2023 - Wiley Online Library
The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches

R Gheorghita, I Soldanescu, A Lobiuc… - Frontiers in …, 2024 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been
defined as the greatest global health and socioeconomic crisis of modern times. While most …

[HTML][HTML] Long COVID and significant activity limitation among adults, by age—United States, June 1–13, 2022, to June 7–19, 2023

ND Ford - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
Long COVID is a condition encompassing a wide range of health problems that emerge,
persist, or return following COVID-19. CDC analyzed national repeat cross-sectional …

Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study

T Ballouz, D Menges, A Anagnostopoulos… - Bmj, 2023 - bmj.com
Objective To evaluate longer term symptoms and health outcomes associated with post-
covid-19 condition within a cohort of individuals with a SARS-CoV-2 infection. Design …

[HTML][HTML] Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in …

M Roessler, F Tesch, M Batram, J Jacob, F Loser… - PLoS …, 2022 - journals.plos.org
Background Long-term health sequelae of the Coronavirus Disease 2019 (COVID-19) are a
major public health concern. However, evidence on post-acute COVID-19 syndrome (post …

Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study

R Morello, F Mariani, L Mastrantoni, C De Rose… - …, 2023 - thelancet.com
Background Adults and children can develop post-Covid-19 condition (PCC)(also referred to
as Long Covid). However, existing evidence is scarce, partly due to a lack of a standardised …

Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study

L Lundberg-Morris, S Leach, Y Xu, J Martikainen… - Bmj, 2023 - bmj.com
Objective To investigate the effectiveness of primary covid-19 vaccination (first two doses
and first booster dose within the recommended schedule) against post-covid-19 condition …

Post COVID-19 condition, work ability and occupational changes in a population-based cohort

P Kerksieck, T Ballouz, SR Haile… - The Lancet Regional …, 2023 - thelancet.com
Background Evidence on the impact of post COVID-19 condition (PCC) on work ability is
limited but critical due to its high prevalence among working-age individuals. This study …

Fighting Post-COVID and ME/CFS–development of curative therapies

C Scheibenbogen, JT Bellmann-Strobl… - Frontiers in …, 2023 - frontiersin.org
The sequela of COVID-19 include a broad spectrum of symptoms that fall under the umbrella
term post-COVID-19 condition or syndrome (PCS). Immune dysregulation, autoimmunity …

Long COVID in pediatrics—epidemiology, diagnosis, and management

N Toepfner, F Brinkmann, S Augustin… - European Journal of …, 2024 - Springer
This review summarizes current knowledge on post-acute sequelae of COVID-19 (PASC)
and post-COVID-19 condition (PCC) in children and adolescents. A literature review was …